The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) ...
September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to ...
September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...
September 9, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip ...
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...
September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...
September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY ...
Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and ...
September 7, 2022 — Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...
September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...